Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Current management of Coats disease.

Sigler EJ, Randolph JC, Calzada JI, Wilson MW, Haik BG.

Surv Ophthalmol. 2014 Jan-Feb;59(1):30-46. doi: 10.1016/j.survophthal.2013.03.007. Epub 2013 Oct 15. Review.

PMID:
24138893
2.

Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.

Ramasubramanian A, Shields CL.

Br J Ophthalmol. 2012 Mar;96(3):356-9. doi: 10.1136/bjophthalmol-2011-300141. Epub 2011 Jun 7.

PMID:
21653215
3.

Successful use of intravitreal bevacizumab and pascal laser photocoagulation in the management of adult Coats' disease.

Raoof N, Quhill F.

Middle East Afr J Ophthalmol. 2013 Jul-Sep;20(3):256-8. doi: 10.4103/0974-9233.114805.

4.
5.

Pearls and pitfalls in diagnosis and management of coats disease.

Grosso A, Pellegrini M, Cereda MG, Panico C, Staurenghi G, Sigler EJ.

Retina. 2015 Apr;35(4):614-23. doi: 10.1097/IAE.0000000000000485. Review.

PMID:
25811949
6.

Diagnostic and therapeutic challenges.

Querques G, Lattanzio R, Querques L, Bandello F, Freund KB.

Retina. 2013 Jan;33(1):240-3. doi: 10.1097/IAE.0b013e31826710d5. No abstract available.

PMID:
23095768
7.

[Idiopathic macular telangiectasia: clinical appearance, imaging and treatment].

De Bats F, Denis P, Kodjikian L.

J Fr Ophtalmol. 2013 Feb;36(2):164-71. doi: 10.1016/j.jfo.2012.09.002. Epub 2012 Nov 27. Review. French.

8.

Treatment of Coats' disease with intravitreal bevacizumab.

Ray R, Barañano DE, Hubbard GB.

Br J Ophthalmol. 2013 Mar;97(3):272-7. doi: 10.1136/bjophthalmol-2012-302250. Epub 2012 Dec 25.

PMID:
23269680
9.

[Adjuvant anti-VEGF therapy in Coats' disease].

Fiorentzis M, Stavridis E, Seitz B, Viestenz A.

Ophthalmologe. 2015 May;112(5):451-4. doi: 10.1007/s00347-014-3122-0. German.

PMID:
25134462
10.

Intraoperative spectral-domain optical coherence tomography in coats' disease.

Henry CR, Berrocal AM, Hess DJ, Murray TG.

Ophthalmic Surg Lasers Imaging. 2012 Jul 26;43 Online:e80-4. doi: 10.3928/15428877-20120719-01.

PMID:
22827477
11.

Coats disease in a patient with Fanconi anemia: a case report.

Martín-Sanz R, Peña D, López-Miguel A, Coco-Martín MB, González-García H, Álvarez-Guisasola FJ, Pastor JC.

Eur J Ophthalmol. 2015 Mar-Apr;25(2):182-3. doi: 10.5301/ejo.5000517. Epub 2014 Sep 11.

PMID:
25264118
12.

A combination of intravitreal bevacizumab injection with tunable argon yellow laser photocoagulation as a treatment for adult-onset Coats' disease.

Wang KY, Cheng CK.

J Ocul Pharmacol Ther. 2011 Oct;27(5):525-30. doi: 10.1089/jop.2011.0088. Epub 2011 Sep 27.

PMID:
21951171
13.

Retinal telangiectasis detected during a vision screening examination in a child with hearing loss led to the diagnosis of facioscapulohumeral muscular dystrophy.

Lee GD, Chen VM, Barnes AC, Goldman DR, Duker JS.

J AAPOS. 2014 Jun;18(3):303-5. doi: 10.1016/j.jaapos.2014.02.009.

PMID:
24924285
14.

Intravitreal bevacizumab for type 2 idiopathic macular telangiectasia.

Veloso CE, Vianna RN, Pelayes DE, Nehemy MB.

Ophthalmic Res. 2013;49(4):205-8. doi: 10.1159/000346130. Epub 2013 Jan 29.

PMID:
23364325
15.

Retinoschisis in the setting of Coats' disease.

Yannuzzi NA, Tzu JH, Hess DJ, Berrocal AM.

Ophthalmic Surg Lasers Imaging Retina. 2014 Mar-Apr;45(2):172-4. doi: 10.3928/23258160-20140306-13.

PMID:
24635161
16.

Efficacy of anti-vascular endothelial growth factor therapy in subretinal neovascularization secondary to macular telangiectasia type 2.

Narayanan R, Chhablani J, Sinha M, Dave V, Tyagi M, Pappuru RR, Kuppermann BD.

Retina. 2012 Nov-Dec;32(10):2001-5. doi: 10.1097/IAE.0b013e3182625c1d.

PMID:
22990322
17.

"Mommy... I Can't See With My Eye". Coats disease with foveal exudation (Stage 2b).

Yeung HH.

J Pediatr Ophthalmol Strabismus. 2016 Mar-Apr;53(2):76-7, 89. doi: 10.3928/01913913-20160218-01. No abstract available.

PMID:
27018878
18.

Intravitreal bevacizumab for perifoveal telangiectasia.

Jonas JB, Libondi T, von Baltz S, Beutelspacher S.

Acta Ophthalmol. 2011 Nov;89(7):e607-8. doi: 10.1111/j.1755-3768.2010.02007.x. Epub 2010 Oct 14. No abstract available.

19.

TRANSCLERAL DRAINAGE OF SUBRETINAL FLUID, ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR, AND WIDE-FIELD IMAGING-GUIDED LASER IN COATS EXUDATIVE RETINAL DETACHMENT.

Stanga PE, Jaberansari H, Bindra MS, Gil-Martinez M, Biswas S.

Retina. 2016 Jan;36(1):156-62. doi: 10.1097/IAE.0000000000000669.

PMID:
26355946
20.

Diagnostic and Therapeutic Challenges.

Corvi F, Lattanzio R, Miserocchi E, Querques L, Bandello F, Querques G, Croft DE, Wykoff CC.

Retina. 2016 Nov;36(11):2239-2245. No abstract available.

PMID:
27322945

Supplemental Content

Support Center